Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 19, 2002

View Archived Issues

Viragen and U. of Miami collaborate on immune enhancing drug for cancer

Rheumatoid arthritis test receives FDA approval

Serono updates second quarter progress

Oxagen and Pfizer enter target validation collaboration

Enrollment initiated in phase III atamestane trial

British Biotech and GeneSoft enter antibiotics drug discovery collaboration

Columbia submits NDA for testosterone buccal bioadhesive product

New backup compound for AD presented at ACS

MSI-1436 prevents the homeostatic metabolic response induced by decreased feeding in rats

SAR on novel PDE5 inhibitors reported by Pfizer

New ECTA-based antibacterial compounds designed at NewBiotics

Interferon inducers described by Sumitomo and Japan Energy at ACS meeting

Antifungal agents with anti-CaNMT activity designed at Nippon Roche

New 5-HT reuptake inhibitors identified at Lilly

Roche claims novel OSLC inhibitors in recent patent

New GABA-A receptor modulators and their use as anesthetics, sedatives, etc.

New antibacterial compounds in early development at GSK

Antibacterial streptogramin derivatives designed at Aventis Pharma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...